Johnson & Johnson Appoints Daniel Pinto to Board of Directors

Details

Mr. Pinto, currently President of JPMorganChase, will serve on the Audit and Compensation & Benefits Committees. He will receive compensation as outlined in the Company's 2025 Proxy Statement. JPMorganChase, a key banking service provider to Johnson & Johnson, received approximately $39.2 million from the Company in fiscal year 2024 for various banking services.

Items reported

Exhibits (1)

About Johnson & Johnson

Johnson & Johnson is a multinational corporation engaged in the research, development, production, and sale of a broad range of healthcare products. Primarily known for its pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson has a significant presence in the global healthcare industry. It develops medications for a variety of fields such as immunology, oncology, neurology, infectious diseases, and vaccines. The company also produces a wide array of medical devices for surgery, orthopedics, and cardiovascular health. In addition to pharmaceuticals, Johnson & Johnson is renowned for its consumer health products, including baby care, skin and hair care, wound care, and over-the-counter pharmaceuticals, with well-recognized brands like Band-Aid, Tylenol, and Neutrogena. Operating globally, the corporation's extensive portfolio and commitment to healthcare innovation make it a pivotal player in the industry, ensuring it remains influential in addressing worldwide health challenges and advancing medical technology.